Precigen - PGEN Stock Price

Brandmark of precigen.com (PGEN)

Precigen, Inc. (PGEN) specializes in synthetic biology, developing personalized treatments for diabetes and cancer through proprietary platforms. This chart reflects the price action of the asset, which is currently valued at 4.67. The business model relies on the expansive cell technology market, where massive initial R&D investments are offset in the future by minimal costs for producing patented drugs.

PGEN - Precigen, Inc. Market Price over the range 07/04/2022 - 11/12/2026

Precigen Inc - analytical breakdowns and key metrics (PGEN)

- stock value and consensus price forecast:
Price Chart Precigen, Inc.|PGEN - Forecast Levels Chart
- issuer market value details:
Market Capitalization Precigen Inc|PGEN - Full Takeover Company Value
- book capitalization information:
Book Value per Share Precigen|PGEN - Total Stockholders' Equity|Market Value to Book Value Ratio precigen.com|PGEN - Total Business Assets
- debt and liquidity data:
Debt to Equity Precigen, Inc.|PGEN - Long-Term Liabilities to Equity|Short-Term Debt to Capital Intrexon|PGEN - Aggregate Debt Obligations|Debts to Book Capitalization Precigen Inc|PGEN - Company Long-Term Debts|Company Short-Term Debt Precigen|Quick Liquidity precigen.com
- earnings and market ratios statistics:
PGEN - Net Income|Projected Future Earnings Precigen, Inc.|PGEN - P/E Multiple|Projected Price to Earnings Precigen|PGEN - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Precigen Inc|PGEN - Operating income before deduction of amortization|Earnings per share for the last twelve months Precigen|PGEN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months precigen.com|PGEN - Net earnings per share growth this year|Expected earnings per share growth for next year Precigen, Inc.
Fundamental valuation:Precigen, Inc.
Signature product of Precigen Inc

Price reflects the market equilibrium between supply and demand, mirroring the asset's current capitalization. Investors utilize volatility amplitude to assess the degree of market risk and potential yield. By analyzing the dynamics of exchange quotes, one can identify the market's reaction to significant events. For Precigen, Inc. (PGEN), volatility is driven by the anticipation of approval for innovative gene therapies. Quotes reflect speculative expectations regarding the company's transition toward the commercial realization of its products.

Analysis of competing companies

Price Chart argenx SE (ARGX)|BNTX: Quote Chart|Stock Price ABVX (Abivax)|Price Rate Chart ADMA Biologics Inc|Protagonist Therapeutics Inc - Stock Price|Market Price Immunovant Therapeutics|Kiniksa Pharmaceuticals (KNSA) - Price Chart|Share Price GRFS|Price Chart Adaptive Biotechnologies Corporation|Celldex Therapeutics Inc - Quote Chart|Stock Price AUPH|BCRX (BioCryst Corp) - Price Performance Chart|Stock Price VERA (Vera Therapeutics, Inc.)|Stock Price dianthustx.com DNTH|PHVS - Price Chart|Price Performance Chart ABCL (abcellera.com)|Tourmaline Corp (TRML) - Price Chart|Stock Quotes Pharming Corp|NKTR (Nektar Therapeutics) - Stock Price|Stock Price upstreambio.com|Stock Quotes ZBIO (Zenas Biopharma)|IMNM (Immunome Inc) - Price Performance Chart|Stock Price GOSS (Gossamer Corp)|Market Chart KalVista Corp (KALV)|SEPN - Price Chart|pieris.com (PVLA) - Stock Quotes|Savara (SVRA) - Price Chart|Stock Quotes Rigel Pharma|Stock Quotes ANAB|Stock Price Astria Corp|Price Chart enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Share Price|Stock Price JBIO (Aerovate Therapeutics)|Aclaris Therapeutics Inc. (ACRS) - Market Price|KYTX - Price Chart|Quote Chart TLSA|Cabaletta Bio, Inc. (CABA) - Price Chart|ventyxbio.com - Price Performance Chart|THTX (Theratechnologies) - Stock Price|Market Price Avalo Therapeutics, Inc. AVTX|Stock Price ELDN|Stock Quotes Agenus, Inc AGEN|Stock Price CLYM (Climb Bio Inc)|Market Chart Zura Bio Ltd (ZURA)|aTyr Pharma - Stock Price|Price Rate Chart Adagene (ADAG)|IMA: Stock Price|Market Price Shattuck Labs (STTK)|Price Chart Equillium Inc|Share Price CNTB (Connect Pharma)|Stock Quotes IMUX (Immunic, Inc.)|ATRA (atarabio.com) - Price Performance Chart|Stock Price IFRX (InflaRx)|Market Chart X4 Pharmaceuticals, Inc (XFOR)|ACET - Price Chart|CELU (Celularity Inc.) - Share Price|INMB: Stock Price|Stock Quotes Barinthus Biotherapeutics PLC|Stock Quotes KZR|SAB Biotherapeutics Inc (SABS) - Market Chart|Price Chart Akari Therapeutics (AKTX)|ENLV: Quote Chart|Stock Price QTTB (Q32 Bio)|Price Rate Chart GeoVax Labs|Edesa - Stock Price|Market Price iBio Corporation|carismatx.com (CARM) - Price Chart|Share Price XTLB|Price Chart Bolt Biotherapeutics Inc.|HCW Biologics Inc - Quote Chart|Stock Price APVO|AIM (AIM ImmunoTech, Inc.) - Price Performance Chart|Stock Price ADTX (Aditxt, Inc.)|Stock Price gribio.com GRI|XRTX - Price Chart|Price Performance Chart HIND (Vyome Holdings Inc.)|Revelation Bio (REVB) - Price Chart|Stock Quotes Indaptus Corp|SCNI (Scinai Immunotherapeutics) - Stock Price|Stock Price CalciMedica Corp|Stock Quotes AFMD (Affimed)|ALLK (allakos.com) - Price Performance Chart|Stock Price HOOK (HOOKIPA Pharma)|Market Chart IGM Biosciences Inc. (IGMS)|ITOS - Price Chart|oceanbiomedical.com (OCEA) - Stock Quotes|TC BioPharm (TCBP) - Price Chart|Stock Quotes Third Harmonic Bio Inc.